25I

Fluzoparib

Created:	2022-12-06
Last modified:	2024-05-01

Find Related PDB Entry
2 entries where 25I is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	50
Chiral Atom Count	0
Bond Count	54
Aromatic Bond Count	17

2D diagram of 25I

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	Fluzoparib
Synonyms	SHR3162
Systematic Name (OpenEye OEToolkits)	4-[[4-fluoranyl-3-[[2-(trifluoromethyl)-6,8-dihydro-5~{H}-[1,2,4]triazolo[1,5-a]pyrazin-7-yl]carbonyl]phenyl]methyl]-2~{H}-phthalazin-1-one
Formula	C₂₂ H₁₆ F₄ N₆ O₂
Molecular Weight	472.395
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	CACTVS	3.385	Fc1ccc(CC2=NNC(=O)c3ccccc23)cc1C(=O)N4CCn5nc(nc5C4)C(F)(F)F
SMILES	OpenEye OEToolkits	2.0.7	c1ccc2c(c1)C(=NNC2=O)Cc3ccc(c(c3)C(=O)N4CCn5c(nc(n5)C(F)(F)F)C4)F
Canonical SMILES	CACTVS	3.385	Fc1ccc(CC2=NNC(=O)c3ccccc23)cc1C(=O)N4CCn5nc(nc5C4)C(F)(F)F
Canonical SMILES	OpenEye OEToolkits	2.0.7	c1ccc2c(c1)C(=NNC2=O)Cc3ccc(c(c3)C(=O)N4CCn5c(nc(n5)C(F)(F)F)C4)F
InChI	InChI	1.06	InChI=1S/C22H16F4N6O2/c23-16-6-5-12(10-17-13-3-1-2-4-14(13)19(33)29-28-17)9-15(16)20(34)31-7-8-32-18(11-31)27-21(30-32)22(24,25)26/h1-6,9H,7-8,10-11H2,(H,29,33)
InChIKey	InChI	1.06	XJGXCBHXFWBOTN-UHFFFAOYSA-N

Drug Info: DrugBank

DrugBank ID	DB15637
Name	Fluzoparib
Groups	investigational
Description	Fluzoparib is under investigation in clinical trial NCT03863860 (A Trial of Maintenance Treatment With Fluzoparib Versus Placebo in Relapsed Ovarian Cancer Patients).
Synonyms	Fluzoparib
Categories	Antineoplastic Agents Enzyme Inhibitors Poly(ADP-ribose) Polymerase Inhibitors Pyridazines
CAS number	1358715-18-0

Related Resource References

Resource Name	Reference
Pharos	CHEMBL3930624
PubChem	56649297
ChEMBL	CHEMBL3930624

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.